R1317
Pharmaceutical compound
From Wikipedia, the free encyclopedia
R1317 is a desmethylprodine analog in which the N-methyl group is replaced by a cinnamyl group. This change in sidechain endows the compound with an increase in potency. The compound is 261 times more potent[clarification needed] than meperidine in mice[1] and 1100 times more potent in rats. In another article it was stated to be 785 times more potent than meperidine.[2]
Other names1-Cinnamyl-4-phenyl-4-piperidinol propionate
| Clinical data | |
|---|---|
| Other names | 1-Cinnamyl-4-phenyl-4-piperidinol propionate |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H27NO2 |
| Molar mass | 349.474 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Despite this high potency, it is not the most potent 4-phenylpiperidine-reverse ester ever created. The most potent 4-phenylpiperidine-reverse ester ever created is R1480.[1] R1480 is stated to have a potency 1500-3180 times higher than meperidine in mice and 3040 times higher in rats.
